论文部分内容阅读
三氧化二砷(arsenic trioxide,As203,AT)为中药砒霜的主要成分,20世纪70年代我国学者发现其治疗急性早幼粒细胞白血病(APL)有特效,1999年As203正式通过国家药品监督管理局的审批临床治疗APL,并于2000作为治疗复发性及耐药性APL的新药通过美国食品及药物管理局(FDA)
Arsenic trioxide (As203, AT) is the main component of arsenic in Chinese medicine. In the 1970s, Chinese scholars found that it has the special effect of treating acute promyelocytic leukemia (APL). In 1999 As203 formally passed the examination and approval of the State Drug Administration Treatment of APL and in 2000 as a New Drug for the Treatment of Relapsed and Aplastic APL By the United States Food and Drug Administration (FDA)